Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(26 sites) United States
University of California, San Diego (UCSD), San Diego, California University of Michigan, Ann Arbor, Michigan Australia
Royal Prince Alfred Hospital, Camperdown, New South Wales Royal Brisbane Hospital, Herston, Queensland Royal Adelaide Hospital, Adelaide, South Australia The Alfred Hospital, Melbourne, Victoria Canada
McMaster University - Hamilton, Hamilton, Ontario Hong Kong
Queen Mary Hospital, Hong Kong Prince of Wales Hospital Chinese University of Hong Kong, Shatin Israel
Sheba Medical Center, Tel Litwinsky Mexico
Centro de Investigacion Clinica GRAMEL S.C., Mexico City, Mexico City Saudi Arabia
King Faisal Specialist Hospital and Research Center, Riyadh Singapore
National University Hospital, Singapore Singapore General Hospital, Singapore South Africa
Haemophilia Comprehensive Care Centre, Johannesburg South Korea
Kyungpook National University Hospital, Daegu Kyung Hee University Hospital at Gangdong, Seoul Severance Hospital, Yonsei University Health System, Seoul Taiwan
Tri-Service General Hospital, Taipei, Neihu District Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City, Sanmin District Changhua Christian Hospital (CCH), Chang-hua Taichung Veterans General Hospital -, Taichung National Taiwan University Hospital, Taipei Turkey (Türkiye)
Ege University Medical Faculty, Bornova Gaziantep University Sahinbey Research and Practice Hospital, Gaziantep Özel Acibadem Adana Hastanesi, Seyhan